Most Read Articles
Naomi Rodrig, 15 Jun 2016
An interim analysis from the multinational phase III CASTOR trial, presented recently at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, showed that adding daratumumab to the standard two-drug regimen of bortezomib and dexamethasone markedly improved outcomes of patients with recurrent or refractory multiple myeloma.
Su Ping Chuah, 01 Aug 2014

New immune therapies with new targets that can induce long-term remission in patients with advanced cutaneous T-cell lymphoma (CTCL) are needed, says an expert.

Tristan Manalac, 25 Feb 2017
Compared with viral hepatocellular carcinomas and those of other aetiologies, cryptogenic hepatocellular carcinomas tend to manifest at later stages and are associated with worse survival, according to a study presented at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL 2017).
Radha Chitale, 01 Aug 2014

German experts came together to update guidelines on melanoma management and create consensus out of fragmented standards of care by experts across multiple fields.

Altered microbiomes in breast tissue, urine of breast cancer patients

20 Oct 2017

Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.

The study included 57 invasive breast cancer patients (mean age 55±14 years) who underwent mastectomy and 21 noncancer controls (mean age 43±14 years) who received cosmetic procedures. Taxa abundance was determined through sequencing of the 16s rRNA gene and subsequent bioinformatic analysis.

Compared to noncancer patients, the abundance of the genus Methylobacterium was significantly lower (p=0.03) and the relative abundance of an unknown genus of family Alcaligenaceae was significantly higher in tumour tissue from cancer patients (p=0.01).

In breast cancer patients, genus Methylobacterium was also relatively more abundant in normal tissue than in malignant tissue, but the difference did not reach significance.

Microbial diversity was also significantly higher in breast cancer patients who were hormone receptor-positive than in those who were not (p=0.03).

For the urine microbiome analysis, investigators used samples from 46 cancer patients and 19 noncancer participants, which showed comparable total number of 16s rRNA gene reads (p=0.15).

After controlling for menopausal status, significantly higher levels of the gram-positive bacteria Corynebacterium, Actinomyces and Staphylococcus were observed in breast cancer patients than in noncancer participants.

Bacterial diversity was also significantly greater in the urine samples collected from cancer patients than in noncancer participants.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Naomi Rodrig, 15 Jun 2016
An interim analysis from the multinational phase III CASTOR trial, presented recently at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, showed that adding daratumumab to the standard two-drug regimen of bortezomib and dexamethasone markedly improved outcomes of patients with recurrent or refractory multiple myeloma.
Su Ping Chuah, 01 Aug 2014

New immune therapies with new targets that can induce long-term remission in patients with advanced cutaneous T-cell lymphoma (CTCL) are needed, says an expert.

Tristan Manalac, 25 Feb 2017
Compared with viral hepatocellular carcinomas and those of other aetiologies, cryptogenic hepatocellular carcinomas tend to manifest at later stages and are associated with worse survival, according to a study presented at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL 2017).
Radha Chitale, 01 Aug 2014

German experts came together to update guidelines on melanoma management and create consensus out of fragmented standards of care by experts across multiple fields.